EUVIMEDEUVIMED entdecken
Crossref

Measuring Direct Oral Anticoagulant Levels in Laboratory Practice: Impact of Different Storage Conditions of Blood Samples

Andrea Sorrentino iD, Angela Rogolino, Francesca Cesari, Alessia Bertelli iD, Giulia Ciarrocca Taranta, Michela Di Gioia, Anna Maria Gori, Betti Giusti, Daniela Poli, Armando Tripodi, Rossella Marcucci

International Journal of Laboratory Hematology · 2025

DOI: 10.1111/ijlh.70042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2025. Verfasst von Andrea Sorrentino und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Anticoagulants, Blood Specimen Collection, Drug Monitoring. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Finanziato dall'Unione europea-Next Generation EU, Missione 4 Componente 1 CUP, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Direct oral anticoagulants (DOACs) have simplified anticoagulant therapy, but plasma level testing (i.e., anti‐Xa and anti‐IIa activities) remains important in specific clinical situations (e.g., emergency surgery, bleeding, renal impairment, or suspected non‐adherence). However, the impact of sample storage on assay reliability is not well defined. This study evaluated the stability and potential systematic errors in DOACs (apixaban, rivaroxaban, edoxaban, dabigatran) plasma levels after 24 h storage under different conditions.

Methods

We enrolled 182 patients on one of the four DOACs. Blood samples were collected in duplicate citrated tubes. The first tube was processed within 4 h to obtain baseline values, with plasma successively stored at room temperature, 4°C, and −20°C for 24 h. The second tube was stored as whole blood at room temperature before measuring DOACs concentrations. DOACs were measured using dedicated clotting or chromogenic assays. Stability was assessed using non‐parametric statistics, Passing‐Bablok regression, and Bland–Altman analysis, with Acceptable Change Limits based on assay variability.

Results

All DOACs showed good stability across conditions, with median recoveries ranging from 93% to 102%. No significant proportional errors were observed. Minor constant biases were observed for apixaban (at 4°C and −20°C), and more consistently for rivaroxaban and edoxaban. Dabigatran showed no significant bias. Variability was generally low (< 7%), and most measurements near clinical thresholds remained accurate.

Conclusion

DOACs plasma levels remain stable after 24 h storage under various conditions. While minor biases exist, particularly for rivaroxaban and edoxaban, they are unlikely to affect clinical interpretation in most cases. Whenever needed, DOACs measurement can be deferred after blood drawing without jeopardizing results interpretation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsBlood Specimen CollectionDrug MonitoringHumansAdministration, OralMaleFemaleRivaroxabanBlood Coagulation TestsAgedPyridonesReproducibility of ResultsMiddle AgedPyridinesThiazoles

Stichwörter der Autor:innen

DOACs level monitoringanticoagulantsapixabanblood specimen handlingdabigatrandrug stabilityedoxabanrivaroxaban

Substanzen

AnticoagulantsRivaroxabanedoxabanPyridonesPyridinesThiazoles

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Unit of Atherothrombotic Diseases, Careggi University Hospital, Florence, Italy.
  • IRCCS Ca' Granda Maggiore Hospital Foundation, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano, Italy.

ORCID-Profile: Andrea Sorrentino, Alessia Bertelli

Förderung

  • Finanziato dall'Unione europea-Next Generation EU, Missione 4 Componente 1 CUP
  • European Commission

Zitieren

APA

Sorrentino, A., Rogolino, A., Cesari, F., Bertelli, A., Taranta, G. C., Di Gioia, M., Gori, A. M., Giusti, B., Poli, D., Tripodi, A., & Marcucci, R. (2025). Measuring Direct Oral Anticoagulant Levels in Laboratory Practice: Impact of Different Storage Conditions of Blood Samples. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.70042

Vancouver

Sorrentino A, Rogolino A, Cesari F, Bertelli A, Taranta GC, Di Gioia M, et al. Measuring Direct Oral Anticoagulant Levels in Laboratory Practice: Impact of Different Storage Conditions of Blood Samples. International Journal of Laboratory Hematology. 2025. doi:10.1111/ijlh.70042

BibTeX
@article{Sorrentino2025,
  author = {Sorrentino, Andrea and Rogolino, Angela and Cesari, Francesca and Bertelli, Alessia and Taranta, Giulia Ciarrocca and Di Gioia, Michela and Gori, Anna Maria and Giusti, Betti and Poli, Daniela and Tripodi, Armando and Marcucci, Rossella},
  title = {Measuring Direct Oral Anticoagulant Levels in Laboratory Practice: Impact of Different Storage Conditions of Blood Samples},
  journal = {International Journal of Laboratory Hematology},
  year = {2025},
  doi = {10.1111/ijlh.70042}
}
Kostenlos starten →